Discontinuation report BASAGLAR

Last updated on 2019-08-23 History
Report ID 75765
Drug Identification Number 02444852
Brand name BASAGLAR
Common or Proper name insulin glargine (rDNA origin)
Company Name ELI LILLY CANADA INC
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size KwikPen, 3 mL prefilled pen, in packages of 5
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date 2019-08-30
Actual discontinuation date 2019-08-22
Remaining supply date 2019-08-22
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply The Basaglar KWIKPEN DIN 02444852 which delivers up to 60 UNITS PER INJECTION DELIVERY is no longer available and has been replaced by the Basaglar KWIKPEN DIN 02461528 which DELIVERS UP TO 80 UNITS PER INJECTION.
Company comments The Basaglar KWIKPEN DIN 02444852 which delivers up to 60 UNITS PER INJECTION DELIVERY has been discontinued and replaced by the Basaglar KWIKPEN DIN 02461528 which DELIVERS UP TO 80 UNITS PER INJECTION.
Health Canada comments
Contact Address 3650 DANFORTH AVENUE
TORONTO, ONTARIO
CANADA M1N 2E8
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2019-08-23 English Compare
v16 2019-08-22 French Compare
v15 2019-08-22 English Compare
v14 2019-08-22 English Compare
v13 2019-03-26 French Compare
v12 2019-03-26 English Compare
v11 2019-02-19 French Compare
v10 2019-02-19 English Compare
v9 2019-02-15 French Compare
v8 2019-02-15 English Compare
v7 2019-02-15 English Compare
v6 2019-02-14 French Compare
v5 2019-02-14 English Compare
v4 2019-02-14 French Compare
v3 2019-02-14 English Compare
v2 2019-02-14 English Compare
v1 2019-02-14 English Compare